{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:59:22Z","timestamp":1762459162333,"version":"3.37.3"},"reference-count":59,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T00:00:00Z","timestamp":1395273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 HD069199"],"award-info":[{"award-number":["K23 HD069199"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NR012642"],"award-info":[{"award-number":["R01 NR012642"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI36219"],"award-info":[{"award-number":["P30 AI36219"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2014,10]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\u2010infected patients on antiretroviral therapy (<jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content>) have an increased cardiovascular disease (<jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content>) risk as a result of heightened inflammation and immune activation, despite at times having normal lipids and few traditional risk factors. Biomarkers are needed to identify such patients before a clinical event. Lipoprotein\u2010associated phospholipase <jats:styled-content style=\"fixed-case\">A<jats:sub>2<\/jats:sub><\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content>) predicts <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content> events in the general population. This study investigated the relationship between <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> and markers of <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content> risk, systemic inflammation, immune activation, and coagulation in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>One hundred subjects on stable <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> with normal fasting low\u2010density lipoprotein (<jats:styled-content style=\"fixed-case\">LDL<\/jats:styled-content>) cholesterol were enrolled in the study. Plasma <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> concentrations were measured by enzyme\u2010linked immunosorbent assay (<jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>; &gt;\u2009200\u2009ng\/mL was considered high <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content> risk). Subclinical atherosclerosis, endothelial function, inflammation, immune activation and fasting lipids were also evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median age of the patients was 47 years and 77% were male. Median (range) <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> was 209 (71\u2013402) ng\/mL. Fifty\u2010seven per cent of patients had <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> concentrations &gt;\u2009200\u2009ng\/mL. <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> was positively correlated with soluble markers of inflammation or immune activation (tumour necrosis factor receptor\u2010<jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>, intercellular and vascular cellular adhesion molecules, and <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>14; all <jats:italic><jats:styled-content style=\"fixed-case\">R<\/jats:styled-content><\/jats:italic>\u2009=\u20090.3; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01), and negatively correlated with coagulation markers (<jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>\u2010dimer and fibrinogen; both <jats:italic><jats:styled-content style=\"fixed-case\">R<\/jats:styled-content><\/jats:italic>\u2009=\u2009\u22120.2; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.04). <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> was not correlated with lipids, coronary artery calcium score, or flow\u2010mediated vasodilation, but trended towards a significant correlation with carotid intima\u2010media thickness (<jats:italic><jats:styled-content style=\"fixed-case\">R<\/jats:styled-content><\/jats:italic>\u2009=\u20090.2; <jats:italic>P<\/jats:italic>\u2009=\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this population with stable <jats:styled-content style=\"fixed-case\">ART<\/jats:styled-content> and normal <jats:styled-content style=\"fixed-case\">LDL<\/jats:styled-content> cholesterol, <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> was in the high <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content> risk category in the majority of subjects. <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> appears to be associated with inflammation\/immune activation, but also with anti\u2010thrombotic effects. <jats:styled-content style=\"fixed-case\">Lp\u2010PLA<jats:sub>2<\/jats:sub><\/jats:styled-content> may represent a valuable early biomarker of <jats:styled-content style=\"fixed-case\">CVD<\/jats:styled-content> risk in <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content> infection before subclinical atherosclerosis can be detected.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hiv.12143","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T01:48:49Z","timestamp":1395366529000},"page":"537-546","source":"Crossref","is-referenced-by-count":15,"title":["Lipoprotein\u2010associated phospholipase <scp>A<sub>2<\/sub><\/scp> and cardiovascular disease risk in <scp>HIV<\/scp> infection"],"prefix":"10.1111","volume":"15","author":[{"given":"A","family":"Ross Eckard","sequence":"first","affiliation":[{"name":"Emory University School of Medicine and Children's Healthcare of Atlanta  Atlanta GA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CT","family":"Longenecker","sequence":"additional","affiliation":[{"name":"Case Western Reserve University  Cleveland OH USA"},{"name":"Rainbow Babies and Children's Hospital and University Hospitals Case Medical Center  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Jiang","sequence":"additional","affiliation":[{"name":"Case Western Reserve University  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SM","family":"Debanne","sequence":"additional","affiliation":[{"name":"Case Western Reserve University  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Labbato","sequence":"additional","affiliation":[{"name":"Case Western Reserve University  Cleveland OH USA"},{"name":"Rainbow Babies and Children's Hospital and University Hospitals Case Medical Center  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Storer","sequence":"additional","affiliation":[{"name":"Case Western Reserve University  Cleveland OH USA"},{"name":"Rainbow Babies and Children's Hospital and University Hospitals Case Medical Center  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GA","family":"McComsey","sequence":"additional","affiliation":[{"name":"Case Western Reserve University  Cleveland OH USA"},{"name":"Rainbow Babies and Children's Hospital and University Hospitals Case Medical Center  Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-2190"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/518285"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305230-00010"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832d3b85"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1086\/605578"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050203"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181a9992c"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiq071"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12013"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.7.891"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.7.898"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(96)05851-0"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199704033361401"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000052939.59093.45"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707402"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.09.001"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.165712"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.018"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(11)60992-0"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000160551.21962.a7"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/1354750X.2012.664170"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60319-4"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi010"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.19.2073"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.151670"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000116763.91992.F1"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143377.53389.C8"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2006.01.011"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.019"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/039463201202500127"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.08.010"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1785"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0003319711420608"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.086298"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000240406.89440.0c"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000226198.44181.0c"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040967"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.101.18.2149"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.12.4219"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2297"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.14.1799"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f560d9"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2007.11.011"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1983"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2006.00362.x"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20432"},{"key":"e_1_2_6_48_1","first-page":"E\u201067","article-title":"Lipoprotein\u2010associated phospholipase A2 is not increased in association with insulin resistance [abstract]","volume":"24","author":"McLaughlin T","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000181011.62385.91"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431603"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000191655.87296.ab"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.04.004"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000148322.89911.44"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.04.014"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.612630"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.066845"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl361"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2012.09.054"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.11.079"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1870"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhiv.12143","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hiv.12143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T14:04:54Z","timestamp":1696341894000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hiv.12143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["10.1111\/hiv.12143"],"URL":"https:\/\/doi.org\/10.1111\/hiv.12143","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"type":"print","value":"1464-2662"},{"type":"electronic","value":"1468-1293"}],"subject":[],"published":{"date-parts":[[2014,3,20]]}}}